Recently, we identified a new pathway by which TGFβ/PKA/PP2A signaling deactivates Akt phosphorylation leading to downregulation of IAPs, XIAP and survivin in colorectal cancer (CRC) cells[10,11]. This evidence concerns the gene TGFB1 and colorectal carcinoma.